Original Research | ||||||||||||||||||||||||||||||
Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies Jayeeta Bhadra, Shiba Ansari, Meena Singh.
|
How to Cite this Article |
Pubmed Style Bhadra J, Ansari S, Singh M, . Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep. Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 Web Style Bhadra J, Ansari S, Singh M, . Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. https://www.mdpub.net/?mno=138301 [Access: February 24, 2023]. doi:10.5455/IJMRCR.172-1673369494 AMA (American Medical Association) Style Bhadra J, Ansari S, Singh M, . Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep. Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 Vancouver/ICMJE Style Bhadra J, Ansari S, Singh M, . Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep, [cited February 24, 2023]; Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 Harvard Style Bhadra, J., Ansari, S., Singh, M. & (2023) Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. Int J Med Rev Case Rep, Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 Turabian Style Bhadra, Jayeeta, Shiba Ansari, Meena Singh, and . 2023. Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. International Journal of Medical Reviews and Case Reports, Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 Chicago Style Bhadra, Jayeeta, Shiba Ansari, Meena Singh, and . "Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies." International Journal of Medical Reviews and Case Reports Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 MLA (The Modern Language Association) Style Bhadra, Jayeeta, Shiba Ansari, Meena Singh, and . "Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies." International Journal of Medical Reviews and Case Reports Online First: 04 Feb, 2023. Web. 24 Feb 2023 doi:10.5455/IJMRCR.172-1673369494 APA (American Psychological Association) Style Bhadra, J., Ansari, S., Singh, M. & (2023) Serum Free Light Chain ratio: Utility as marker of residual disease in monoclonal gammopathies. International Journal of Medical Reviews and Case Reports, Online First: 04 Feb, 2023. doi:10.5455/IJMRCR.172-1673369494 |